Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease

Neurology

Volumn 49, Issue 1, 1997, Pages 56-61

  Kang, D E ^a   Saitoh, T ^a   Chen, X ^a   Xia, Y ^a   Masliah, E ^a   Hansen, L A ^a   Thomas, R G ^a   Thal, L J ^a   Katzman, R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; FEMALE; GENETIC MARKER; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENILE PLAQUE;

EID: 0030752288     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.49.1.56     Document Type: Article

References (33)

1. Schellenberg GD. Genetic dissection of Alzheimer disease, a heterogeneous disorder. Proc Natl Acad Sci USA 1995;92: 8552-8559.
2. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995;375:754-760.
3. Rogaev EI, Sherrington R, Rogaeva EA, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995;283:4228-4229.
4. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
5. Roses AD. Apolipoprotein E affects the rate of Alzheimer disease expression: β-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol 1994;53:429-437.
6. Castano E, Prelli F, Wisniewski T, et al. Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. Biochem J 1995;306:599-604.
7. LaDu MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE. Isoform-specific binding of apolipoprotein E to β-amyloid. J Biol Chem 1994;269:23403-23406.
8. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 1994;264:850-852.
9. Holtzman D, Pitas R, Killbridge J, et al. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc Natl Acad Sci USA 1995;92: 9480-9484.
10. Bellosta S, Nathan BP, Orth M, Dong LM, Mahley RW, Pitas RE. Stable expression and secretion of apolipoprotein E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J Biol Chem 1995;270:27063-27071.
11. 2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain. Am J Pathol 1992;141:37-42.
12. 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann Neurol 1995; 37:211-217.
13. Strickland DK, Kounnas MZ, Argraves SW. LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism. FASEB J 1995;9:890-898.
14. Kounnas MZ, Moir RD, Rebeck GW, et al. LDL-receptor-related protein, a multifunctional apoE receptor, binds secreted β-amyloid precursor protein and mediated its degradation. Cell 1995;82:331-340.
15. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993;11:575-580.
16. Hansen LA, Galasko D, Samuel W, et al. Apolipoprotein ∈4 is associated with increased neurofibrillary pathology in Lewy body variant of Alzheimer's disease. Neurosci Lett 1994;182: 63-65.
17. Olichney JM, Hansen LA, Galasko MD, et al. The apolipoprotein E ∈4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 1996;47:190-196.
18. Ozcelik H, Andrulis I. Multiplex PCR-SSCP for simultaneous screening for mutations in several exons of p53. Biotechniques 1995;18:742-744.
19. Galasko D, Saitoh T, Xia Y, Thai LJ, Katzman R, Hill LR, Hansen L. The apolipoprotein E allele ∈4 is over-represented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994;44:1950-1951.
20. Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimer's disease in a community population of older persons. JAMA 1989;262:2551-2556.
21. Corder EH, Saunders AM, Risch NJ, et al. Gene dosage of apoliprotein E type 4 allele and risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
22. Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984;120: 885-890.
23. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid β-peptide deposition in cerebral cortices as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993;90:9649-9653.
24. Beisiegl U, Krapp A, Weber W, Olivecrona G. The role of α 2M receptor/LRP in chylomicron remnant metabolism. Ann NY Acad Sci 1994;737:53-69.
25. 1-antichymotrypsin polymorphism. Nat Genet 1995;10:486-488.
26. Okuizumi K, Onodera O, Namba Y, et al. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nature Genet 1995;11:207-209.
27. Wragg M, Hutton M, Talbot C, Group. AC. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Lancet 1996;347:509-512.
28. 1-antichymotrypsin in Alzheimer's disease. Genomics 1996;33:53-56.
29. Okuizumi K, Onodera O, Seki K, et al. Lack of association of very low density lipoprotein receptor gene polymorphism with Caucasian Alzheimer's disease. Ann Neurol 1996;40:251-254.
30. Kerem B-S, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245: 1073-1080.
31. 2-macroglobulin receptor lipoprotein receptor-related protein. Genomics 1994;24:78-89.
32. Tanaka S, Shiojiri S, Takahashi Y, et al. Tissue-specific expression of three types of β-protein precursor mRNA: enhancement of protease inhibitor-harboring types in Alzheimer's disease brain. Biochem Biophys Res Commun 1989;165: 1406-1414.
33. Johnson SA, McNeil T, Cordell B, Finch CE. Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease. Science 1990;248:854-857.